Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Lipid rafts are cholesterol- and sphingolipid-enriched microdomains in cell membranes that regulate phosphorylation cascades originating from membrane-bound proteins. In this study, we tested whether alteration of the cholesterol content of lipid rafts in prostate cancer (PCa) cell membranes affects cell survival mechanisms in vitro and in vivo. Simvastatin, a cholesterol synthesis inhibitor, lowered raft cholesterol content, inhibited Akt1 serine-threonine kinase (protein kinase Balpha)/protein kinase B (Akt/PKB) pathway signaling, and induced apoptosis in caveolin- and PTEN-negative LNCaP PCa cells. Replenishing cell membranes with cholesterol reversed these inhibitory and apoptotic effects. Cholesterol also potentiated Akt activation in normal prostate epithelial cells, which were resistant to the apoptotic effects of simvastatin. Elevation of circulating cholesterol in SCID mice increased the cholesterol content and the extent of protein tyrosine phosphorylation in lipid rafts isolated from LNCaP/sHB xenograft tumors. Cholesterol elevation also promoted tumor growth, increased phosphorylation of Akt, and reduced apoptosis in the xenografts. Our results implicate membrane cholesterol in Akt signaling in both normal and malignant cells and provide evidence that PCa cells can become dependent on a cholesterol-regulated Akt pathway for cell survival.

[1]  Jayoung Kim,et al.  Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function. , 2002, Endocrinology.

[2]  D. Tindall,et al.  Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. , 2001, Endocrinology.

[3]  Henk-Jan Guchelaar,et al.  The risk of cancer in users of statins. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Brian J. Bennett,et al.  Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[5]  P. Walsh A prospective study on the intake of animal products and risk of prostate cancer. , 2002, The Journal of urology.

[6]  T. Wheeler,et al.  Elevated caveolin-1 levels in African-American versus white-American prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  P. Sehgal,et al.  Cytokine Signaling , 2002, The Journal of Biological Chemistry.

[8]  G. Bu,et al.  Low-density lipoprotein receptor family: endocytosis and signal transduction. , 2001, Molecular neurobiology.

[9]  T. Thompson,et al.  Caveolin-1 Maintains Activated Akt in Prostate CancerCells through Scaffolding Domain Binding Site Interactions with andInhibition of Serine/Threonine Protein Phosphatases PP1 andPP2A , 2003, Molecular and Cellular Biology.

[10]  Richard G. W. Anderson,et al.  Multiple Functions of Caveolin-1* , 2002, The Journal of Biological Chemistry.

[11]  M. Loda,et al.  Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. , 1999, Cancer research.

[12]  W. Sessa,et al.  The Sonic Hedgehog Receptor Patched Associates with Caveolin-1 in Cholesterol-rich Microdomains of the Plasma Membrane* 210 , 2001, The Journal of Biological Chemistry.

[13]  O. Halvorsen,et al.  Combined loss of PTEN and p27 expression is associated with tumor cell proliferation by Ki-67 and increased risk of recurrent disease in localized prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  P. L. Becker,et al.  Cholesterol Depletion Inhibits Epidermal Growth Factor Receptor Transactivation by Angiotensin II in Vascular Smooth Muscle Cells , 2001, The Journal of Biological Chemistry.

[15]  David S. Park,et al.  Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. , 2003, Molecular biology of the cell.

[16]  Yu-Sheng Chao,et al.  Simvastatin Has Anti-Inflammatory and Antiatherosclerotic Activities Independent of Plasma Cholesterol Lowering , 2001 .

[17]  P. Hauschka,et al.  Caveolae in Human and Murine Osteoblasts , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[18]  L. Pike Lipid rafts Published, JLR Papers in Press, February 1, 2003. DOI 10.1194/jlr.R200021-JLR200 , 2003, Journal of Lipid Research.

[19]  J. Thrasher,et al.  Hedgehog signaling promotes prostate xenograft tumor growth. , 2004, Endocrinology.

[20]  N. Vaziri,et al.  Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCγ-1 and tyrosine kinase-Ras pathways. , 1999, American journal of physiology. Renal physiology.

[21]  G. Blackburn,et al.  Inhibition of orthotopic growth and metastasis of androgen‐sensitive human prostate tumors in mice by bioactive soybean components , 2002, The Prostate.

[22]  K. Sandvig,et al.  Caveolae: anchored, multifunctional platforms in the lipid ocean. , 2003, Trends in cell biology.

[23]  Richard J. Lee,et al.  Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo , 1998, The Journal of Biological Chemistry.

[24]  G. Thorgeirsson,et al.  Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. , 2000, The American journal of cardiology.

[25]  M. Freeman,et al.  Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. , 2002, Cancer research.

[26]  M. Lisanti,et al.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. , 1996, The Journal of biological chemistry.

[27]  M. Marcelli,et al.  Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. , 1998, Cancer research.

[28]  M Dietel,et al.  Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. , 2001, The American journal of pathology.

[29]  Y. Chen,et al.  Human prostate cancer cells lack feedback regulation of low‐density lipoprotein receptor and its regulator, SREBP2 , 2001, International journal of cancer.

[30]  E. Rimm,et al.  A prospective study on intake of animal products and risk of prostate cancer , 2001, Cancer Causes & Control.

[31]  M. Drab,et al.  Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.

[32]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[33]  S. Fagan,et al.  Pharmacology and clinical experience with simvastatin , 2001, Expert opinion on pharmacotherapy.

[34]  J. Soria,et al.  Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. , 2001, Carcinogenesis.

[35]  P. Cohen,et al.  Role of Translocation in the Activation and Function of Protein Kinase B* , 1997, The Journal of Biological Chemistry.

[36]  C. Elson,et al.  Sterol‐independent regulation of 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase in tumor cells , 2001, Molecular carcinogenesis.

[37]  D. S. Coffey Similarities of prostate and breast cancer: Evolution, diet, and estrogens. , 2001, Urology.

[38]  C. Sawyers,et al.  The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Pike,et al.  Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. , 1996, Molecular biology of the cell.

[40]  E. Rimm,et al.  A prospective study of tomato products, lycopene, and prostate cancer risk. , 2002, Journal of the National Cancer Institute.

[41]  J. Richie,et al.  Caveolin-1 Interacts with Androgen Receptor , 2001, The Journal of Biological Chemistry.

[42]  A. Walker,et al.  Statin use, hyperlipidaemia, and the risk of breast cancer , 2002, British Journal of Cancer.

[43]  E. Fisher,et al.  Effects of Simvastatin on Plasma Lipoproteins and Response to Arterial Injury in Wild-Type and Apolipoprotein-E-Deficient Mice , 2004, Journal of Vascular Research.

[44]  Jayoung Kim,et al.  Involvement of cholesterol-rich lipid rafts in interleukin-6-induced neuroendocrine differentiation of LNCaP prostate cancer cells. , 2004, Endocrinology.

[45]  R. Adam,et al.  The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. , 1999, Cancer research.

[46]  E. Metter,et al.  Association of energy intake with prostate cancer in a long-term aging study: Baltimore Longitudinal Study of Aging (United States). , 2003, Urology.

[47]  M. Edidin Membrane Cholesterol, Protein Phosphorylation, and Lipid Rafts , 2001, Science's STKE.

[48]  L. Truong,et al.  Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. , 1999, Cancer research.

[49]  B. Hemmings,et al.  Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.

[50]  Kelvin K. W. Chan,et al.  The statins as anticancer agents. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  M. Freeman,et al.  Cholesterol and prostate cancer , 2004, Journal of cellular biochemistry.

[52]  M. Andjelkovic,et al.  Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  David S. Park,et al.  Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. , 2002, The American journal of pathology.

[54]  W. Aronson,et al.  Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States) , 2002, Cancer Causes & Control.

[55]  P. Walsh Hedgehog signalling in prostate regeneration, neoplasia and metastasis. , 2005, The Journal of urology.

[56]  G. Alton,et al.  Identification of a Structural Determinant , 2002 .

[57]  J. Soria,et al.  Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. , 2003, Cellular signalling.

[58]  T. Oshikiri,et al.  Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma , 2002, British Journal of Cancer.

[59]  R. Pearson,et al.  Direct Identification of Tyrosine 474 as a Regulatory Phosphorylation Site for the Akt Protein Kinase* 210 , 2002, The Journal of Biological Chemistry.

[60]  C. Ren,et al.  Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. , 2001, Cancer research.

[61]  C. Rogers,et al.  Simvastatin Reduces Neointimal Thickening in Low-Density Lipoprotein Receptor–Deficient Mice After Experimental Angioplasty Without Changing Plasma Lipids , 2002, Circulation.

[62]  J. Woodgett,et al.  Multiple Phosphoinositide 3-Kinase-Dependent Steps in Activation of Protein Kinase B , 2002, Molecular and Cellular Biology.

[63]  B. Hemmings,et al.  Identification of a Plasma Membrane Raft-Associated PKB Ser473 Kinase Activity that Is Distinct from ILK and PDK1 , 2002, Current Biology.

[64]  S. Okushiba,et al.  Overexpression of caveolin‐1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage , 2002, Cancer.

[65]  K. Solomon,et al.  Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells. , 1998, The Biochemical journal.

[66]  M. Datta,et al.  Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. F. Hoyt,et al.  The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.